EUVIMEDEUVIMED entdecken
Crossref

Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis

Jiang Pi, Yuhe Ma, Wandang Wang, Huanshao Huang, Yuhe Huang, Jiajun Wang, Jiaxiang Li, Xinen Kong, Xiaoying Jin, Sheng Liu, Jiali Cai, Yanguang Cong und 5 weitere

International Immunopharmacology · 2025-12 · 167 · 115696

DOI: 10.1016/j.intimp.2025.115696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Jiang Pi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Dongguan Key Laboratory for Pathogenesis and Experimental Diagnosis of Infectious Diseases, The First Dongguan Affiliated Hospital, School of Medical…. Hauptthemen laut MEDLINE: Rifampin, RNA, Circular, Exosomes, Mycobacterium tuberculosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), a highly lethal infectious diseases induced by Mycobacterium tuberculosis (Mtb) infection, continues to be a major challenge in the realm of infectious diseases. Functional circular RNAs (circRNAs) have been extensively reported to play crucial immunological regulatory roles in Mtb infection and TB development. Our previous researches have demonstrated that CircRNA TRAPPC6B (circTRAPPC6B) can enhance autophagy in Mtb infected macrophages to facilitate intracellular Mtb inhibition/clearance, while how to expand the potential of circTRAPPC6B for effective anti-TB treatment remains a considerable challenge. Here, we innovated a novel macrophage-targeted exosome system, designated as Man-Rif@CircRNA@Exo, which encapsulates circTRAPPC6B and rifampicin to synchronize targeted antibiotic killings and host immunological defenses against Mtb. Man-Rif@CircRNA@Exo exhibited selective macrophage targeting effects attributable to mannose modification and then accumulated into lysosomes of macrophages. Furthermore, Man-Rif@CircRNA@Exo treatment significantly increased intracellular circTRAPPC6B level, which in turn promoted autophagy of Mtb infected macrophages, thereby accelerating host immunological clearance of Mtb. Collectively, Man-Rif@CircRNA@Exo indicated enhanced intracellular Mtb killing efficiency by synergizing targeted rifampicin bacteriocidal action with autophagy-mediated host immunological clearance against Mtb. This synergistic anti-TB approach significantly reduced Mtb burdens and alleviated tissue pathology and inflammation in the lungs of Mtb-infected mice, without significantly affecting liver/kidney structure and functional parameters to show acceptable safety. These results highlight the promising potential of Man-Rif@CircRNA@Exo to synchronize targeted antibiotic action and host immunological defenses for more effective anti-TB treatment, which is anticipated to advance the development of novel host directed therapeutics against TB and drug-resistant TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinRNA, CircularExosomesMycobacterium tuberculosisImmunotherapyTuberculosisAnimalsMiceMacrophagesHumansAutophagyMice, Inbred C57BLRAW 264.7 Cells

Stichwörter der Autor:innen

CircRNAsDrug deliveryExosomesHost immune defenseMacrophage targetingTuberculosis

Substanzen

RifampinRNA, Circular

Autor:innen und Institutionen

  • Dongguan Key Laboratory for Pathogenesis and Experimental Diagnosis of Infectious Diseases, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan, China; Guangdong…
  • Dongguan Key Laboratory for Pathogenesis and Experimental Diagnosis of Infectious Diseases, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan, China.
  • Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Research Center of Nano Technology and Application Engineering, Songshan Lake Innovation Center of Medicine & Engineering, School of M…
  • Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, USA.
  • Department of Blood Transfusion, Shenzhen Third People's Hospital, Shenzhen, China. Electronic address: yifanhuang0220@163.com.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Pi, J., Ma, Y., Wang, W., Huang, H., Huang, Y., Wang, J., Li, J., Kong, X., Jin, X., Liu, S., Cai, J., Cong, Y., Gong, H., Shen, L., Huang, Y., Huang, X., & Xu, J. F. (2025). Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis. International Immunopharmacology, 167, 115696. https://doi.org/10.1016/j.intimp.2025.115696

Vancouver

Pi J, Ma Y, Wang W, Huang H, Huang Y, Wang J, et al. Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis. International Immunopharmacology. 2025;167:115696. doi:10.1016/j.intimp.2025.115696

BibTeX
@article{Pi2025,
  author = {Pi, Jiang and Ma, Yuhe and Wang, Wandang and Huang, Huanshao and Huang, Yuhe and Wang, Jiajun and Li, Jiaxiang and Kong, Xinen and Jin, Xiaoying and Liu, Sheng and Cai, Jiali and Cong, Yanguang and Gong, Haiyan and Shen, Ling and Huang, Yifan and Huang, Xueqin and Xu, Jun-Fa},
  title = {Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {167},
  pages = {115696},
  doi = {10.1016/j.intimp.2025.115696}
}
Kostenlos starten →